Pharma giant GlaxoSmithKline has been hit with yet another marketing violation. The drugmaker has paid $105 million to more than 40 American states who filed suit against GSK for promoting off-label uses for its antidepressants. But financial payouts are proving little more than slaps on the wrist for the repeat offender who continues to engage in illegal promotional strategies.
Imagine being able to grow part of an organ in a lab – and then run tests on its functioning in order to truly understand how best to treat a particular condition. Rather than use human subjects to test new therapies, which involves costly and complex pharmaceutical quality control protocols, researchers could develop customized treatments using genetically engineered samples. Organ-on-a-chip Scientists from Harvard’s Wyss Institute, Boston Children’s Hospital, and the Harvard School of Engineering and Applied Sciences have collaborated to revolutionize clinical research with new organ-on-a-chip technology. Using patient stem cells, the team actually engineered part of a heart. The.. READ MORE »
Canadians are plagued by skyrocketing drug prices, and in many cases are unable to afford life-saving treatments. Big Pharma defends its position, maintaining that an influx of cheap generics has forced it to inflate name brand pricing.
Despite promises to clean up its suspect drug promotion practices, GlaxoSmithKline sales reps have been charged with bribing Polish doctors to boost prescriptions of company products.
Within recent years, there’s been an explosion of pet-related products and vigorous marketing campaigns to promote them – gourmet foods, designer outerwear, luxurious accessories. Mainstream media has aggressively promoted pets as valued family members, and most of us know a dog or two who is pampered and protected on par with a newborn baby! The status gap between domestic animals and their owners is quickly diminishing. So, it’s no wonder that clinical research and pharmaceutical drug discovery is devoting increased resources to pet meds – drugs that address conditions we would normally associate with humans, but that afflict that increasingly.. READ MORE »
It’s like owning the world’s first spaceship; an incredibly powerful and cutting-edge device capable of speeding across the universe. But there’s no guidance system. So, you end up either flying in circles, or colliding disastrously with an interstellar object. Many of the most innovative compounds that enter clinical trials suffer a similar fate.
Most of us, even those who wouldn’t call themselves pet-friendly, would love to see an end to animal lab testing. But the truth is, the practice remains central to our discovery of essential new medicines. Every new therapy from cancer treatments to neurological therapies is first tested for safety on animals before being administered to humans. With few viable alternatives, clinical research and drug discovery has continued to rely on animal testing as an unavoidable evil. That is, until now. Focused on finding more humane solutions, scientists around the world are coming up with some astonishingly innovative animal-free testing options… READ MORE »
When we think about our favourite apps, social media sites or video games, chances are we’re not considering how they might improve our health, further clinical research, or even save lives in the operating room. Doctors, healthcare professionals and patients are increasingly engaged with digital devices – technology that may have begun as entertainment, but has now evolved to hold a much more impactful place in our lives. Take a look at three of the most talked about tech trends that are changing the landscape of traditional health care. Quantitative Self and Personalized Big Data A new movement.. READ MORE »
Available in several Toronto wellness clinics and featured on a recent episode of Dr. Oz, intravenous vitamin therapy is gaining traction as a natural way to combat everything from low energy to advanced cancer. But does it really work? Nobel prize-winning scientist Linus Pauling thought so, and his well respected clinical research on the benefits of vitamin C goes back as far as the 1970s. Since then, researchers have continued to test the effects of super-high doses of vitamin C on terminal cases of cancer. And the results have meant years of successful remission for numerous patients. These days, vitamin.. READ MORE »
From Big Pharma to biotech, research scientists to practicing clinicians – the industry is intently focused on developing more highly effective drug delivery systems. In recent years, clinical research has revealed innovative solutions in the form of nanodiamonds, microneedles, gold particles, silk and protein clusters; all of which represent a step forward with regard to precision and patient safety. It’s all about effectively targeted techniques that offer professionals better ways to administer medicines, track their effectiveness, and minimize unwanted side-effects. And now scientists have discovered what may prove to be the most significant advance yet – electronically controlled drugs that.. READ MORE »
